Presentation is loading. Please wait.

Presentation is loading. Please wait.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Published bySolomon Carpenter Modified over 6 years ago

Similar presentations

Presentation on theme: "Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the."— Presentation transcript:

1 Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method  Karyn A. Goodman, MD, MS, Caroline E. Patton, MA, George A. Fisher, MD, PhD, Sarah E. Hoffe, MD, Michael G. Haddock, MD, Parag J. Parikh, MD, John Kim, MD, Nancy N. Baxter, MD, PhD, Brian G. Czito, MD, Theodore S. Hong, MD, Joseph M. Herman, MD, MS, Christopher H. Crane, MD, Karen E. Hoffman, MD  Practical Radiation Oncology  Volume 6, Issue 3, Pages (May 2016) DOI: /j.prro Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

2 Figure 1 Appropriateness of neoadjuvant short-course radiation therapy. Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

3 Figure 2 Appropriateness of neoadjuvant chemotherapy alone.
Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

4 Figure 3 Appropriateness of no neoadjuvant therapy.
Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

5 Figure 4 Appropriateness of adjuvant chemoradiation (plus ≥4 months of chemotherapy). Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

6 Figure 5 Appropriateness of adjuvant chemotherapy alone.
Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

7 Figure 6 Appropriateness of definitive endorectal brachytherapy. ECOG, Eastern Cooperative Oncology Group. Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

8 Figure 7 Appropriateness of definitive chemoradiation plus endorectal brachytherapy. ECOG, Eastern Cooperative Oncology Group. Practical Radiation Oncology 2016 6, DOI: ( /j.prro ) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Download ppt "Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the."

Similar presentations

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer: Rethinking neoadjuvant treatment  Matthew C. Biagioli, MD, MS,

Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer: Rethinking neoadjuvant treatment  Matthew C. Biagioli, MD, MS,
Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database  Brigid K. Killelea, MD,

Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database  Brigid K. Killelea, MD,
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
US radiation oncology practice patterns for posttreatment survivor care  Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

US radiation oncology practice patterns for posttreatment survivor care  Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.
Volume 143, Issue 5, Pages e437S-e454S (May 2013)

Volume 143, Issue 5, Pages e437S-e454S (May 2013)
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients  John M.

Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients  John M.
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary  Lawrence B. Marks, MD, Robert.

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary  Lawrence B. Marks, MD, Robert.
Brenda G. Clark, PhD, Robert J

Brenda G. Clark, PhD, Robert J

Similar presentations

Ads by Google